Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 15;18(1):623.
doi: 10.1186/s12889-018-5545-z.

Drug prescribing during pregnancy in a central region of Italy, 2008-2012

Martina Ventura  1 , Alice Maraschini  2 , Paola D'Aloja  2 , Ursula Kirchmayer  3 , Ilaria Lega  2 , Marina Davoli  3 , Serena Donati  2
Affiliations

Drug prescribing during pregnancy in a central region of Italy, 2008-2012

Martina Ventura et al. BMC Public Health. .

Abstract

Background: Drug consumption during pregnancy is a matter of concern, especially regarding drugs known or suspected to be teratogens. Little is known about drug use in pregnant women in Italy. The present study is aimed at examining the prevalence, and to detect potential inappropriateness of drug prescribing among pregnant women in Latium, a region of central Italy.

Methods: This retrospective study was conducted on a cohort of women aged 18-45 years who delivered between 2008 and 2012 in public hospitals. Women were enrolled through the Regional Birth Register. After linking the regional Health Information Systems and the Regional Drug Claims Register, women's clinical data and prescribed medications were analyzed. Italian Medicine Agency (AIFA) and US Food and Drug Administration (FDA) evidence were used to investigate inappropriate prescribing and teratogenic risk.

Results: Excluding vitamins and minerals, 80.6% (n = 153,079) of the women were prescribed at least one drug during pregnancy, with an average of 4.6 medications per pregnancy. Drugs for blood and hematopoietic organs were the most commonly prescribed (53.0%,), followed by anti-infectives for systemic use (50.7%). Among the inappropriate prescriptions, progestogen supplementation was given in 20.1% of pregnancies; teratogen drugs were prescribed in 0.8%, mostly angiotensin co-enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) (0.3%).

Conclusions: In Latium, drugs are widely used in pregnancy. Prescriptions of inappropriate drugs are observed in more than a fifth of pregnancies, and teratogens are still used, despite their known risk. Continuous updates of information provided to practitioners and an increased availability of information to women might reduce inappropriate prescribing.

Keywords: Health information system; Inappropriate prescribing; Italy; Pregnancy; Teratogens.

PubMed Disclaimer

Conflict of interest statement

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Shivayogi P. Vulnerable population and methods for their safeguard. Perspect Clin Res. 2013;4(1):53–57. doi: 10.4103/2229-3485.106389. - DOI - PMC - PubMed
    1. Adam MP, Polifka JE, Friedman JM. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am J Med Genet C Semin Med Genet. 2011;157C(3):175–182. doi: 10.1002/ajmg.c.30313. - DOI - PubMed
    1. Thorpe PG, Gilboa SM, Hernandez-Diaz S, et al. Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiol Drug Saf. 2013;22(9):1013–1018. - PMC - PubMed
    1. Sachdeva P, Patel BG, Patel BK. Drug use in pregnancy; a point to ponder! Indian J Pharm Sci. 2009;71(1):1–7. doi: 10.4103/0250-474X.51941. - DOI - PMC - PubMed
    1. FDA Pregnancy and Lactation Labeling (Drugs). http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources.... Accessed 10 Dec 2011.